High-density genomewide linkage analysis of exceptional human longevity identifies multiple novel loci

PLoS ONE

Volumn 5, Issue 8, 2010, Pages

  Boyden, Steven E ^a,b   Kunkel, Louis M ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CHROMOSOME 12P; CHROMOSOME 3P; CHROMOSOME 4Q; CHROMOSOME 9Q; CHROMOSOME ANALYSIS; CONTROLLED STUDY; FAMILY STUDY; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC VARIABILITY; GENOME ANALYSIS; GENOTYPE; HUMAN; LINKAGE ANALYSIS; LONGEVITY; MALE; SCORING SYSTEM; SIBLING; SINGLE NUCLEOTIDE POLYMORPHISM; GENETIC LINKAGE; GENETICS; HUMAN CHROMOSOME; HUMAN GENOME;

AGED, 80 AND OVER; CHROMOSOMES, HUMAN; FEMALE; GENETIC LOCI; GENOME, HUMAN; HUMANS; LINKAGE (GENETICS); LOD SCORE; LONGEVITY; MALE;

EID: 77957955081     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0012432     Document Type: Article

References (96)

1. Vaupel JW, Carey JR, Christensen K, Johnson TE, Yashin AI, et al. (1998) Biodemographic trajectories of longevity. Science 280: 855-860.
2. Vaupel JW, Manton KG, Stallard E (1979) The impact of heterogeneity in individual frailty on the dynamics of mortality. Demography 16: 439-454.
3. Vaupel JW, Yashin AI (1985) Heterogeneity's ruses: some surprising effects of selection on population dynamics. Am Stat 39: 176-185.
4. Hitt R, Young-Xu Y, Silver M, Perls T (1999) Centenarians: the older you get, the healthier you have been. Lancet 354: 652.
5. Fries JF (1980) Aging, natural death, and the compression of morbidity. N Engl J Med 303: 130-135.
6. Browner WS, Kahn AJ, Ziv E, Reiner AP, Oshima J, et al. (2004) The genetics of human longevity. Am J Med 117: 851-860.
7. Christensen K, Johnson TE, Vaupel JW (2006) The quest for genetic determinants of human longevity: challenges and insights. Nat Rev Genet 7: 436-448.
8. Martin GM, Bergman A, Barzilai N (2007) Genetic determinants of human health span and life span: progress and new opportunities. PLoS Genet 3: e125.
9. Davignon J, Bouthillier D, Nestruck AC, Sing CF (1988) Apolipoprotein E polymorphism and atherosclerosis: insight from a study in octogenarians. Trans Am Clin Climatol Assoc 99: 100-110.
10. Schachter F, Faure-Delanef L, Guenot F, Rouger H, Froguel P, et al. (1994) Genetic associations with human longevity at the APOE and ACE loci. Nat Genet 6: 29-32.
11. Lewis SJ, Brunner EJ (2004) Methodological problems in genetic association studies of longevity-the apolipoprotein E gene as an example. Int J Epidemiol 33: 962-970.
12. Novelli V, Viviani Anselmi C, Roncarati R, Guffanti G, Malovini A, et al. (2008) Lack of replication of genetic associations with human longevity. Biogerontology 9: 85-92.
13. Kuningas M, Magi R, Westendorp RG, Slagboom PE, Remm M, et al. (2007) Haplotypes in the human Foxo1a and Foxo3a genes; impact on disease and mortality at old age. Eur J Hum Genet 15: 294-301.
14. Willcox BJ, Donlon TA, He Q, Chen R, Grove JS, et al. (2008) FOXO3A genotype is strongly associated with human longevity. Proc Natl Acad Sci U S A 105: 13987-13992.
15. Flachsbart F, Caliebe A, Kleindorp R, Blanche H, von Eller-Eberstein H, et al. (2009) Association of FOXO3A variation with human longevity confirmed in German centenarians. Proc Natl Acad Sci U S A 106: 2700-2705.
16. Anselmi CV, Malovini A, Roncarati R, Novelli V, Villa F, et al. (2009) Association of the FOXO3A locus with extreme longevity in a southern Italian centenarian study. Rejuvenation Res 12: 95-104.
17. Pawlikowska L, Hu D, Huntsman S, Sung A, Chu C, et al. (2009) Association of common genetic variation in the insulin/IGF1 signaling pathway with human longevity. Aging Cell 8: 460-472.
18. Li Y, Wang WJ, Cao H, Lu J, Wu C, et al. (2009) Genetic association of FOXO1A and FOXO3A with longevity trait in Han Chinese populations. Hum Mol Genet.
19. Cournil A, Kirkwood TB (2001) If you would live long, choose your parents well. Trends Genet 17: 233-235.
20. Hjelmborg Jv, Iachine I, Skytthe A, Vaupel JW, McGue M, et al. (2006) Genetic influence on human lifespan and longevity. Hum Genet 119: 312-321.
21. Perls TT, Wilmoth J, Levenson R, Drinkwater M, Cohen M, et al. (2002) Lifelong sustained mortality advantage of siblings of centenarians. Proc Natl Acad Sci U S A 99: 8442-8447.
22. Gudmundsson H, Gudbjartsson DF, Frigge M, Gulcher JR, Stefansson K (2000) Inheritance of human longevity in Iceland. Eur J Hum Genet 8: 743-749.
23. Kerber RA, O'Brien E, Smith KR, Cawthon RM (2001) Familial excess longevity in Utah genealogies. J Gerontol A Biol Sci Med Sci 56: B130-139.
24. Puca AA, Daly MJ, Brewster SJ, Matise TC, Barrett J, et al. (2001) A genomewide scan for linkage to human exceptional longevity identifies a locus on chromosome 4. Proc Natl Acad Sci U S A 98: 10505-10508.
25. Reed T, Dick DM, Uniacke SK, Foroud T, Nichols WC (2004) Genome-wide scan for a healthy aging phenotype provides support for a locus near D4S1564 promoting healthy aging. J Gerontol A Biol Sci Med Sci 59: 227-232.
26. Beekman M, Blauw GJ, Houwing-Duistermaat JJ, Brandt BW, Westendorp RG, et al. (2006) Chromosome 4q25, microsomal transfer protein gene, and human longevity: novel data and a meta-analysis of association studies. J Gerontol A Biol Sci Med Sci 61: 355-362.
27. Karasik D, Hannan MT, Cupples LA, Felson DT, Kiel DP (2004) Genetic contribution to biological aging: the Framingham Study. J Gerontol A Biol Sci Med Sci 59: 218-226.
28. Geesaman BJ, Benson E, Brewster SJ, Kunkel LM, Blanche H, et al. (2003) Haplotype-based identification of a microsomal transfer protein marker associated with the human lifespan. Proc Natl Acad Sci U S A 100: 14115-14120.
29. Wang T, Elston RC (2005) The bias introduced by population stratification in IBD based linkage analysis. Hum Hered 60: 134-142.
30. Bell FC, Miller ML (2005) Life Tables for the United States Social Security Area 1900-2100. U.S. Social Security Administration. Available: http://www.ssa.gov/OACT/NOTES/as120/TOC.html. Accessed 2009.
31. Abecasis GR, Cherny SS, Cookson WO, Cardon LR (2002) Merlin-rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet 30: 97-101.
32. Kong A, Cox NJ (1997) Allele-sharing models: LOD scores and accurate linkage tests. Am J Hum Genet 61: 1179-1188.
33. Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES (1996) Parametric and nonparametric linkage analysis: a unified multipoint approach. Am J Hum Genet 58: 1347-1363.
34. Cordell HJ (2004) Bias toward the null hypothesis in model-free linkage analysis is highly dependent on the test statistic used. Am J Hum Genet 74: 1294-1302.
35. Abecasis GR, Wigginton JE (2005) Handling marker-marker linkage disequilibrium: pedigree analysis with clustered markers. Am J Hum Genet 77: 754-767.
36. Boyles AL, Scott WK, Martin ER, Schmidt S, Li YJ, et al. (2005) Linkage disequilibrium inflates type I error rates in multipoint linkage analysis when parental genotypes are missing. Hum Hered 59: 220-227.
37. Lander E, Kruglyak L (1995) Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 11: 241-247.
38. North BV, Curtis D, Sham PC (2002) A note on the calculation of empirical P values from Monte Carlo procedures. Am J Hum Genet 71: 439-441.
39. Broman KW, Caffo BS (2003) Simulation-based P values: response to North et al. Am J Hum Genet 72: 496.
40. Ewens WJ (2003) On estimating P values by theMonte Carlo method. Am J Hum Genet 72: 496-498.
41. North BV, Curtis D, Sham PC (2003) A note on calculation of empirical P values from Monte Carlo procedure. Am J Hum Genet 72: 498-499.
42. Clopper CJ, Pearson ES (1934) The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika 26: 404-413.
43. Sauro J, Lewis JR (2005) Estimating completion rates from small samples using binomial confidence intervals: comparisons and recommendations. Proceedings of the Human Factors and Ergonomics Society 49th Annual Meeting 5: 2100-2104.
44. Kruglyak L (1997) The use of a genetic map of biallelic markers in linkage studies. Nat Genet 17: 21-24.
45. Sawcer SJ, Maranian M, Singlehurst S, Yeo T, Compston A, et al. (2004) Enhancing linkage analysis of complex disorders: an evaluation of high-density genotyping. Hum Mol Genet 13: 1943-1949.
46. Middleton FA, Pato MT, Gentile KL, Morley CP, Zhao X, et al. (2004) Genomewide linkage analysis of bipolar disorder by use of a high-density singlenucleotide- polymorphism (SNP) genotyping assay: a comparison with microsatellite marker assays and finding of significant linkage to chromosome 6q22. Am J Hum Genet 74: 886-897.
47. Fishman PM, Suarez B, Hodge SE, Reich T (1978) A robust method for the detection of linkage in familial disease. Am J Hum Genet 30: 308-321.
48. Risch N (1990) Linkage strategies for genetically complex traits. II. The power of affected relative pairs. Am J Hum Genet 46: 229-241.
49. Nemani M, Sahbatou M, Blanche H, Thomas G, Pascoe L (2000) The efficiency of genetic analysis of DNA from aged siblings to detect chromosomal regions implicated in longevity. Mech Ageing Dev 119: 25-39.
50. Gerdes LU, Jeune B, Ranberg KA, Nybo H, Vaupel JW (2000) Estimation of apolipoprotein E genotype-specific relative mortality risks from the distribution of genotypes in centenarians and middle-aged men: apolipoprotein E gene is a ''frailty gene,'' not a ''longevity gene''. Genet Epidemiol 19: 202-210.
51. Utermann G, Hardewig A, Zimmer F (1984) Apolipoprotein E phenotypes in patients with myocardial infarction. Hum Genet 65: 237-241.
52. Hayden KM, Zandi PP, Lyketsos CG, Tschanz JT, Norton MC, et al. (2005) Apolipoprotein E genotype and mortality: findings from the Cache County Study. J Am Geriatr Soc 53: 935-942.
53. Tan Q, Zhao JH, Iachine I, Hjelmborg J, Vach W, et al. (2004) Power of nonparametric linkage analysis in mapping genes contributing to human longevity in long-lived sib-pairs. Genet Epidemiol 26: 245-253.
54. Shojaee S, Sina F, Banihosseini SS, Kazemi MH, Kalhor R, et al. (2008) Genome-wide linkage analysis of a Parkinsonian-pyramidal syndrome pedigree by 500 K SNP arrays. Am J Hum Genet 82: 1375-1384.
55. Risch N, Merikangas K (1996) The future of genetic studies of complex human diseases. Science 273: 1516-1517.
56. Nebel A, Croucher PJ, Stiegeler R, Nikolaus S, Krawczak M, et al. (2005) No association between microsomal triglyceride transfer protein (MTP) haplotype and longevity in humans. Proc Natl Acad Sci U S A 102: 7906-7909.
57. Bathum L, Christiansen L, Tan Q, Vaupel J, Jeune B, et al. (2005) No evidence for an association between extreme longevity and microsomal transfer protein polymorphisms in a longitudinal study of 1651 nonagenarians. Eur J Hum Genet 13: 1154-1158.
58. Neville MJ, Clarke R, Evans JG, Rubinsztein DC, Karpe F (2007) Absence of relationship between MTTP haplotypes and longevity. J Gerontol A Biol Sci Med Sci 62: 202-205.
59. Tan Q, Kruse TA, Christensen K (2006) Design and analysis in genetic studies of human ageing and longevity. Ageing Res Rev 5: 371-387.
60. Risch N (1990) Linkage strategies for genetically complex traits. III. The effect of marker polymorphism on analysis of affected relative pairs. Am J Hum Genet 46: 242-253.
61. Risch N (1992) Corrections to ''Linkage strategies for genetically complex traits. III. The effect of marker polymorphism on analysis of affected relative pairs''. Am J Hum Genet 51: 673-675.
62. Holmans P (1993) Asymptotic properties of affected-sib-pair linkage analysis. Am J Hum Genet 52: 362-374.
63. Jo JY, Gonzalez de Mejia E, Lila MA (2005) Effects of grape cell culture extracts on human topoisomerase II catalytic activity and characterization of active fractions. J Agric Food Chem 53: 2489-2498.
64. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, et al. (2006) Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444: 337-342.
65. Harikumar KB, Aggarwal BB (2008) Resveratrol: a multitargeted agent for ageassociated chronic diseases. Cell Cycle 7: 1020-1035.
66. Michishita E, Nakabayashi K, Ogino H, Suzuki T, Fujii M, et al. (1998) DNA topoisomerase inhibitors induce reversible senescence in normal human fibroblasts. Biochem Biophys Res Commun 253: 667-671.
67. Humbert N, Martien S, Augert A, Da Costa M, Mauen S, et al. (2009) A genetic screen identifies topoisomerase 1 as a regulator of senescence. Cancer Res 69: 4101-4106.
68. Temime-Smaali N, Guittat L, Wenner T, Bayart E, Douarre C, et al. (2008) Topoisomerase IIIalpha is required for normal proliferation and telomere stability in alternative lengthening of telomeres. EMBO J 27: 1513-1524.
69. Lebel M, Spillare EA, Harris CC, Leder P (1999) The Werner syndrome gene product co-purifies with the DNA replication complex and interacts with PCNA and topoisomerase I. J Biol Chem 274: 37795-37799.
70. Wu L, Davies SL, North PS, Goulaouic H, Riou JF, et al. (2000) The Bloom's syndrome gene product interacts with topoisomerase III. J Biol Chem 275: 9636-9644.
71. Yu CE, Oshima J, Fu YH, Wijsman EM, Hisama F, et al. (1996) Positional cloning of the Werner's syndrome gene. Science 272: 258-262.
72. Ellis NA, Groden J, Ye TZ, Straughen J, Lennon DJ, et al. (1995) The Bloom's syndrome gene product is homologous to RecQ helicases. Cell 83: 655-666.
73. Kim JE, Chen J, Lou Z (2008) DBC1 is a negative regulator of SIRT1. Nature 451: 583-586.
74. Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, et al. (2003) Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425: 191-196.
75. Haigis MC, Sinclair DA (2010) Mammalian sirtuins: biological insights and disease relevance. Annu Rev Pathol 5: 253-295.
76. Kaeberlein M, McVey M, Guarente L (1999) The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. Genes Dev 13: 2570-2580.
77. Tissenbaum HA, Guarente L (2001) Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans. Nature 410: 227-230.
78. Rogina B, Helfand SL (2004) Sir2 mediates longevity in the fly through a pathway related to calorie restriction. Proc Natl Acad Sci U S A 101: 15998-16003.
79. Lin SJ, Defossez PA, Guarente L (2000) Requirement of NAD and SIR2 for lifespan extension by calorie restriction in Saccharomyces cerevisiae. Science 289: 2126-2128.
80. Cohen HY, Miller C, Bitterman KJ, Wall NR, Hekking B, et al. (2004) Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 305: 390-392.
81. Mair W, Dillin A (2008) Aging and survival: the genetics of life span extension by dietary restriction. Annu Rev Biochem 77: 727-754.
82. Nemoto S, Fergusson MM, Finkel T (2004) Nutrient availability regulates SIRT1 through a forkhead-dependent pathway. Science 306: 2105-2108.
83. Balistreri CR, Candore G, Colonna-Romano G, Lio D, Caruso M, et al. (2004) Role of Toll-like receptor 4 in acute myocardial infarction and longevity. JAMA 292: 2339-2340.
84. Nebel A, Flachsbart F, Schafer A, Nothnagel M, Nikolaus S, et al. (2007) Role of the toll-like receptor 4 polymorphism Asp299Gly in longevity and myocardial infarction in German men. Mech Ageing Dev 128: 409-411.
85. Lunetta KL, D'Agostino RB, Sr, Karasik D, Benjamin EJ, Guo CY, et al. (2007) Genetic correlates of longevity and selected age-related phenotypes: a genomewide association study in the Framingham Study. BMC Med Genet 8(Suppl 1): S13.
86. Balistreri CR, Colonna-Romano G, Lio D, Candore G, Caruso C (2009) TLR4 polymorphisms and ageing: implications for the pathophysiology of age-related diseases. J Clin Immunol 29: 406-415.
87. Mohler PJ, Schott JJ, Gramolini AO, Dilly KW, Guatimosim S, et al. (2003) Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death. Nature 421: 634-639.
88. Sedlacek K, Stark K, Cunha SR, Pfeufer A, Weber S, et al. (2008) Common genetic variants in ANK2 modulate QT interval: results from the KORA study. Circ Cardiovasc Genet 1: 93-99.
89. Schouten EG, Dekker JM, Meppelink P, Kok FJ, Vandenbroucke JP, et al. (1991) QT interval prolongation predicts cardiovascular mortality in an apparently healthy population. Circulation 84: 1516-1523.
90. Puddu PE, Bourassa MG (1986) Prediction of sudden death from QTc interval prolongation in patients with chronic ischemic heart disease. J Electrocardiol 19: 203-211.
91. Barr CS, Naas A, Freeman M, Lang CC, Struthers AD (1994) QT dispersion and sudden unexpected death in chronic heart failure. Lancet 343: 327-329.
92. Gessert CE, Elliott BA, Haller IV (2002) Dying of old age: an examination of death certificates of Minnesota centenarians. J Am Geriatr Soc 50: 1561-1565.
93. Mohler PJ, Healy JA, Xue H, Puca AA, Kline CF, et al. (2007) Ankyrin-B syndrome: enhanced cardiac function balanced by risk of cardiac death and premature senescence. PLoS One 2: e1051.
94. Kruglyak L, Lander ES (1995) High-resolution genetic mapping of complex traits. Am J Hum Genet 56: 1212-1223.
95. Franceschi C, Bezrukov V, Blanche H, Bolund L, Christensen K, et al. (2007) Genetics of healthy aging in Europe: the EU-integrated project GEHA (GEnetics of Healthy Aging). Ann N Y Acad Sci 1100: 21-45.
96. Roeder K, Bacanu SA, Wasserman L, Devlin B (2006) Using linkage genome scans to improve power of association in genome scans. Am J Hum Genet 78: 243-252.